NCT05079607View on ClinicalTrials.gov

Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions
Irritation/IrritantSensitisation
Interventions
OTHER

Mitopure Topical Formula 1

topical skin cream containing the low dose mitophagy activator Mitopure

OTHER

Mitopure Topical Formula 2

topical skin cream containing the high dose mitophagy activator Mitopure

Trial Locations (1)

M12 4QE

PCR Corp, 667A Stockport Road, Manchester

Sponsors
All Listed Sponsors
collaborator

Princeton Research Corporation

UNKNOWN

lead

Amazentis SA

INDUSTRY

NCT05079607 - Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers | Biotech Hunter | Biotech Hunter